1. Home
  2. ABCL vs LPTH Comparison

ABCL vs LPTH Comparison

Compare ABCL & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$12.87

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
LPTH
Founded
2012
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.1B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ABCL
LPTH
Price
$5.97
$12.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$8.40
$13.33
AVG Volume (30 Days)
6.2M
3.8M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
$37,202,630.00
Revenue This Year
N/A
$83.04
Revenue Next Year
$21.85
$24.83
P/E Ratio
N/A
N/A
Revenue Growth
160.56
17.26
52 Week Low
$2.75
$2.75
52 Week High
$6.79
$18.94

Technical Indicators

Market Signals
Indicator
ABCL
LPTH
Relative Strength Index (RSI) 60.46 41.96
Support Level $5.23 $12.45
Resistance Level $6.65 $13.28
Average True Range (ATR) 0.52 1.60
MACD -0.01 -0.33
Stochastic Oscillator 56.38 2.68

Price Performance

Historical Comparison
ABCL
LPTH

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

Share on Social Networks: